Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals

Published:2024-03-01 Issue:2 Volume:22 Page:90-96
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Pelluri Ranakishor¹²³,Kongara Srikanth²,Nagasubramanian Vanitha Rani⁴^ORCID,Mahadevan Shriraam⁵,Chimakurthy Jithendra³

Affiliation:

1. Department of Pharmacy Practice, Sri Ramachandra Institute of Higher Education Research, (Deemed to be University), Chennai, India.

2. Department of Endocrinology and Metabolism, Endolife Speciality Hospital, Guntur, India.

3. Department of Pharmaceutical Sciences, Vignan's Foundation for Science Technology and Research, (Deemed to be University), Guntur, India.

4. Department of Pharmacy Practice, Jaya College of Paramedical Sciences, College of Pharmacy, Chennai, India.

5. Department of Endocrinology and Metabolism, Sri Ramachandra Institute of Higher Education and Research, (Deemed to be University), Chennai, India.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/met.2023.0218

Reference41 articles.

1. Progress and challenges in anti-obesity pharmacotherapy

2. Cardiovascular and Metabolic Heterogeneity of Obesity

3. European Guidelines for Obesity Management in Adults

4. Long-Term Persistence of Hormonal Adaptations to Weight Loss

5. Obesity in adults: a clinical practice guideline

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP